Obesity Abstracts

Provision of Tier 3 (T3) services as defined in NHS commissioning guidelines are integral to NICE obesity guidelines. Previous surveys have shown that people with obesity face a postcode lottery in accessing them. With the establishment of Integrated Care Boards (ICBs) now responsible for commissioning T3 services, we undertook a survey using Freedom of Information requests to all English ICBs in October 2023 asking for: a comprehensive outline of the T3 obesity care pathways;...

Obesity is an important modifiable risk factor for developing osteoarthritis. Arthroplasty improves mobility and quality of life in those with osteoarthritis. BMI thresholds are mandated by some commissioning bodies in the UK, leading to extended waiting times for arthroplasty. Obesity is associated with increased complications after arthroplasty. It is unknown if these risks can be mitigated by weight loss pre-operatively. Our systematic review and meta-analysis explores the ...

Background: Approximately 15-25% of the world population has non-alcoholic fatty liver disease (NAFLD) and nearly quarter go on to develop non-alcoholic steatohepatitis (NASH). Obesity and T2DM are strong risk factors with prevalence of NAFLD rising to 90% in obesity and 60% in T2DM. Liver biopsy remains the gold standard in diagnosis and prognosis; nevertheless, it is expensive and invasive. The underlying fibrosis stage is key in determining clinical outcome...